Unlocking the secrets of cytotoxic granule proteins

Journal of Leukocyte Biology

Volumn 70, Issue 1, 2001, Pages 18-29

  Smyth, Mark J ^a   Kelly, Janice M ^a   Sutton, Vivien R ^a   Davis, Joanne E ^a   Browne, Kylie A ^a   Sayers, Thomas J ^b   Trapani, Joseph A ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Granulysin; Granzyme; Lymphocyte; Perforin

Indexed keywords

CASPASE; CELL PROTEIN; CYTOTOXIC AGENT; FAS ANTIGEN; GRANZYME A; GRANZYME B; PERFORIN; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; AUTOIMMUNE DISEASE; CELL GRANULE; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; EXOCYTOSIS; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CALCIUM-BINDING PROTEINS; CALRETICULIN; CHEMOKINES; CYTOPLASMIC GRANULES; HUMANS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; RIBONUCLEOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034964252     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Human natural killer cells. Biologic and pathologic aspects
2. Mechanism of lymphocyte-mediated cytotoxicity
3. The molecular mechanism of lymphocyte-mediated tumor cell lysis
4. Cell-mediated cytotoxicity
5. T-cell effector functions: Mechanisms for delivery of cytotoxiclty and help
6. A new model for lethal hit delivery by cytotoxic T lymphocytes
7. Cell-mediated killing: A common mechanism?
8. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
9. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytoxicity
10. Transfection of mouse cytotoxic T lymphocytes with an antisense granzyme A vector reduces lytic activity
11. The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments
12. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes
13. Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation
14. The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes
15. The membrane attack complex of complement
16. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain
17. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity
18. Phosphorylcholine acts as a calcium dependent receptor molecule for lymphocyte perforin
19. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity
20. Perforin: Structure and function
21. Cytosolic delivery of granzyme B by bacterial toxins: Evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin
22. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins
23. Biosynthesis of granulysin, a novel cytolytic molecule
24. Granulysin: A novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells
25. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways
26. An antimicrobial activity of cytolytic T cells mediated by granulysin
27. Biochemical and functional properties of serine esterases in acidic cytoplasmic granules of cytotoxic T lymphocytes
28. Isolation and complete structure of the lymphocyte serine protease granzyme G, a novel member of the granzyme multigene family in murine cytolytic T lymphocytes. Evolutionary origin of lymphocyte proteases
29. Granzymes: A variety of serine protease specificities encoded by genetically distinct subfamilies
30. Dual mechanisms of apoptosis induction by cytolytic lymphoeytes
31. The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity
32. Structure and evolutionary origin of the human granzyme H gene
33. The human cytotoxic T cell granule protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes
34. Activation of recombinant murine cytotoxic cell proteinase-1 requires deletion of an amino-terminal dipeptide
35. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I
36. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor
37. The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes
38. +-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules
39. Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis
40. Specific release of proteoglycans from human natural killer cells during target lysis
41. Co-sedimentation of chondroitin sulfate A glycosaminoglycans and proteoglycans with the cytolytic secretory granules of rat large granular lymphocyte (LGL) tumor cells, and identification of a mRNA in normal and transformed LGL that encodes proteoglycans
42. Apoptosis induced by granzyme B-glycosaminoglycan complexes: Implications for granule-mediated apoptosis in vivo
43. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
44. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I
45. Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I
46. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo
47. Immune function in mice lacking the perforin gene
48. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity
49. Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways
50. Xenospecific cytotoxic T lymphocytes: Potent lysis in vitro and in vivo
51. + increase in the target
52. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: Structural, immunological, and functional similarities
53. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9
54. Perforin and lymphocyte-mediated cytolysis
55. Interferon-γ-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis
56. Purified perforin induces target cell lysis but not DNA fragmentation
57. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions
58. Perforin-dependent nuclear accumulation of granzyme B precedes apoptosis, and is not a consequence of nuclear membrane dysfunction
59. Granzymes (lymphocyte serine proteases): Characterization with natural and synthetic substrates and inhibitors
60. CTL granules: Evolution of vesicles essential for combating virus infections
61. A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene
62. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A
63. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells
64. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity
65. Localization of granzyme B in the nucleus. A putative role in the mechanism of cytotoxic lymphocyte-mediated apoptosis
66. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent
67. Nuclear transport of granzyme B (fragmentin-2). Dependence of perforin in vivo and cytosolic factors in vitro
68. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and Grab nuclear localization
69. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis
70. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis
71. Filamin (280 kDa actin-binding protein) is a caspase substrate, and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis
72. Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis
73. The Ced-3/interleukin 1β converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32
74. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains
75. Processing of the Nedd2 precursor by ICE-like proteases and granzyme B
76. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes
77. Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1
78. Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation
79. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases
80. Granzyme B-induced loss of mitochondrial inner membrane potential (delta psi m) and cytochrome c release are caspase independent
81. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
82. Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them
83. BCL-2 blocks perforin-induced nuclear translocation of granzymes, concomitant with protection against the nuclear events of apoptosis
84. Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation
85. Induction of rapid histone degradation by the cytotoxic T lymphocyte protease granzyme A
86. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A X B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells
87. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes
88. Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity
89. Selective regulation of apoptosis: The cellular serpin proteinase inhibitor-9 prevents granzyme B-mediated but not Fas-mediated cell death
90. A new family of ten murine ovalbumin serpins includes two homologs of protease inhibitor 8, and two homologs of the granzyme B inhibitor (protelnase inhibitor 9)
91. Perforin is essential for control of ectromelia virus but not related poxviruses in mice
92. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes
93. Pox-virus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections
94. Perforin gene defects in familial hemophagocytic lymphohistiocytosis
95. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells
96. Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection
97. Theiler's virus infection of perforin-deficient mice
98. Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring
99. Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice
100. Coxsackievirus B3-induced myocarditis: Perforin exacerbates disease, but plays no detectable role in virus clearance
101. Compromised virus control and augmented perforin-mediated immunopathology in IFN-γ-deficient mice infected with lymphocytic choriomeningitis virus
102. + T cells: In vivo priming and antigen-specific immunity against Listeria monocytogenes
103. + T cells derived from TNF-deficient and TNF/perforin double-deficient mice
104. + CTLs are essential for protective immunity against Encephalitozoon cuniculi infection
105. Trypanosoma cruzi: Roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance
106. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gundii
107. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells
108. Molecular mechanisms of immune-mediated lysis of murine renal cancer: Differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells
109. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxlc effector cells
110. Perforin dependence of natural killer cell-mediated tumor control in vivo
111. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum
112. Decreased tumor surveillance in perforin-deficient mice
113. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by eytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation
114. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease
115. Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses
116. Perforin and IFN-γ are involved in the antitumor effects of antibody-targeted superantigens
117. Redirected perforin-dependent lysis of colon carcinoma by ex-vivo genetically engineered CTL
118. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
119. Differential tumor surveillance by natural killer (NK) and NKT cells
120. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
121. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity
122. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis
123. + T cells by perforin
124. Perforin protects against autoimmunity in lupus-prone mice
125. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A
126. A role for perforin in downregulating T-cell responses during chronic viral infection
127. Linear differentiation of cytotoxic effectors into memory T lymphocytes
128. + T cell homeostasis by pefforin and intefferon-γ
129. + T-cell selection, function, and death in the primary immune response in vivo
130. Mouse T cell associated serine protease I degrades collagen type IV: A structural basis for the migration of lymphocytes through vascular basement membranes
131. Purification of a factor from the granules of a rat natural killer cell line (RNK) that reduces tumor cell growth and changes tumor morphology. Molecular identity with granule serine protease (RNKP-1)
132. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity
133. Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus α-thrombin
134. Extracellular granzymes A and B in humans: Detection of native species during CTL responses in vitro and in vivo